AssistRx Joins Second Annual Drug Channels Leadership Forum as Diamond Sponsor

4 months ago

Invite-only event will address today’s most pressing healthcare system challengesORLANDO, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AssistRx, the advanced…

gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms

4 months ago

ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today…

Medera Strengthens Leadership Team with Three Key Executive Appointments

4 months ago

Clinical operations, regulatory affairs, technical expertise, and corporate leadership additions support advancing gene therapy pipeline for cardiovascular diseasesBOSTON, Sept. 30,…

SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)

4 months ago

No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our…

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension

4 months ago

~ Topline results from the EXPLORE-OSA trial are anticipated in 1Q 2026 ~ RADNOR, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE)…

Precision Optics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

4 months ago

GARDNER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and…

Zenflow Receives FDA 510(k) Clearance for First-of-Its-Kind Single-Use Cystoscope

4 months ago

Spring® Scope delivers the largest working channel of any flexible single-use cystoscope, enhancing visualization and patient comfortSOUTH SAN FRANCISCO, Calif.,…

Stride Autism Centers Named a Winner of the 2025 Iowa Top Workplaces Award

4 months ago

DES MOINES, Iowa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early intervention ABA…

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

4 months ago

The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being…

Umoja Biopharma Announces that UB-VV111 Receives FDA Fast Track Designation for Relapsed/Refractory B-Cell Malignancies

4 months ago

SEATTLE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, the clinical-stage leader of in vivo cell therapies that aim to…